Home » SPECTRUM PHARMACEUTICALS ANNOUNCES THE PRESENTATION OF NEW PRECLINICAL DATA ON APAZIQUONE
SPECTRUM PHARMACEUTICALS ANNOUNCES THE PRESENTATION OF NEW PRECLINICAL DATA ON APAZIQUONE
Spectrum Pharmaceuticals, Inc. announced the presentation of new preclinical data on Apaziquone at the 97th Annual Meeting of the American Association for Cancer Research (AACR) in Washington, DC, earlier this month.
Yahoo News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May